AUTHOR=McClung Joseph M. , Reinardy Jessica L. , Mueller Sarah B. , McCord Timothy J. , Kontos Christopher D. , Brown David A. , Hussain Sabah N. A. , Schmidt Cameron A. , Ryan Terence E. , Green Tom D. TITLE=Muscle cell derived angiopoietin-1 contributes to both myogenesis and angiogenesis in the ischemic environment JOURNAL=Frontiers in Physiology VOLUME=6 YEAR=2015 URL=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2015.00161 DOI=10.3389/fphys.2015.00161 ISSN=1664-042X ABSTRACT=
Recent strategies to treat peripheral arterial disease (PAD) have focused on stem cell based therapies, which are believed to result in local secretion of vascular growth factors. Little is known, however, about the role of ischemic endogenous cells in this context. We hypothesized that ischemic muscle cells (MC) are capable of secreting growth factors that act as potent effectors of the local cellular regenerative environment. Both muscle and endothelial cells (ECs) were subjected to experimental ischemia, and conditioned medium (CM) from each was collected and analyzed to assess myogenic and/or angiogenic potential. In muscle progenitors, mRNA expression of VEGF and its cognate receptors (Nrp1, Flt, Flk) was present and decreased during myotube formation